Alpha Cognition Inc (ACOG)

$8.47 -0.25 (-2.87%)
Market Cap 140.92M
Revenue (ttm) 0.00
Net Income (ttm) -14.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 82,800
Avg Vol 62,224
Day's Range N/A - N/A
Shares Out 16.16M
Stochastic %K 17%
Beta 2.71
Analysts Sell
Price Target $27.50

Company Profile

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatit...

Industry: Biotechnology
Sector: Healthcare
Phone: 604-564-9244
Address:
750 West Pender Street, Suite 1200, Vancouver, Canada
MTBKNG9
MTBKNG9 Sep. 17 at 10:21 PM
$ACOG ...Had the same issue yesterday with Schwab, not good if you have to make a call to buy the stock, been lots of selling last two days so keep an eye out if it drops any lower it could set off a drastic move down....
0 · Reply
GeorgeJonesCountryMusic
GeorgeJonesCountryMusic Sep. 16 at 5:31 PM
$ACOG I’ve been buying shares all the time with Schwab and today got a message stating not eligible for electronic entry. Anybody else use Schwab ?
4 · Reply
AlanHR
AlanHR Sep. 12 at 7:21 PM
$ACOG The transcript of the CF fireside chat is now up on the AC website.
0 · Reply
kubota2323
kubota2323 Sep. 8 at 7:19 PM
$ACOG 50 ma is 9.35 now
0 · Reply
Logic102
Logic102 Sep. 8 at 2:06 PM
$ACOG Nice recent upward movement trend. Is some good sales data news leaking?
1 · Reply
FlowerInTheCellar
FlowerInTheCellar Sep. 8 at 11:40 AM
$ACOG https://www.marketbeat.com/instant-alerts/filing-alyeska-investment-group-lp-has-171-million-stock-holdings-in-alpha-cognition-inc-acog-2025-09-06/
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Sep. 5 at 2:24 PM
$ACOG Did anyone watch the conference? I was busy, unfortunately.
1 · Reply
jumptime
jumptime Sep. 4 at 5:44 PM
$ACOG Nice greenies.
0 · Reply
Logic102
Logic102 Sep. 4 at 1:46 PM
$ACOG I think this is pretty much dead money until more sales data comes out. I'm long term Bullish but have shifted most of my funds from here to LCTX and AVXL where I anticipate large upward moves soon. I respect those who are accumulating for the long haul.
0 · Reply
GeorgeJonesCountryMusic
GeorgeJonesCountryMusic Sep. 3 at 8:08 PM
$ACOG everyone still bullish here? I’ve been adding pretty regularly
1 · Reply
Latest News on ACOG
Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences

Aug 28, 2025, 1:00 PM EDT - 20 days ago

Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q2 2025

Aug 15, 2025, 5:10 PM EDT - 4 weeks ago

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q2 2025

Alpha Cognition Inc. (ACOG) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 7:54 PM EDT - 4 weeks ago

Alpha Cognition Inc. (ACOG) Q2 2025 Earnings Call Transcript

Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update

Aug 14, 2025, 8:30 AM EDT - 4 weeks ago

Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update

Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview

Aug 4, 2025, 8:30 AM EDT - 6 weeks ago

Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview

Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer's Disease

Jul 29, 2025, 8:30 AM EDT - 7 weeks ago

Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer's Disease

Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Study Data at Alzheimer's Association International Conference

Jul 8, 2025, 8:30 AM EDT - 2 months ago

Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Study Data at Alzheimer's Association International Conference

Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury

Jul 1, 2025, 5:05 PM EDT - 2 months ago

Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury

Alpha Cognition: Launching A Differentiated Drug Into A Large Alzheimer's Market Opportunity

May 19, 2025, 4:35 PM EDT - 4 months ago

Alpha Cognition: Launching A Differentiated Drug Into A Large Alzheimer's Market Opportunity

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q1 2025

May 19, 2025, 10:25 AM EDT - 4 months ago

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q1 2025

Alpha Cognition Inc. (ACOG) Q1 2025 Earnings Call Transcript

May 15, 2025, 9:51 PM EDT - 4 months ago

Alpha Cognition Inc. (ACOG) Q1 2025 Earnings Call Transcript

Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview

May 15, 2025, 8:30 AM EDT - 4 months ago

Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview

Alpha Cognition to Report First Quarter 2025 Financial Results and Operating Overview

May 1, 2025, 8:30 AM EDT - 4 months ago

Alpha Cognition to Report First Quarter 2025 Financial Results and Operating Overview

Alpha Cognition, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference

Apr 30, 2025, 7:30 AM EDT - 5 months ago

Alpha Cognition, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference

Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Clinical Data at 2025 Alzheimer's Association International Conference

Apr 28, 2025, 8:30 AM EDT - 5 months ago

Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Clinical Data at 2025 Alzheimer's Association International Conference

Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens

Apr 10, 2025, 8:30 AM EDT - 5 months ago

Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q4 2024

Apr 1, 2025, 4:27 PM EDT - 6 months ago

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q4 2024

Alpha Cognition Inc. (ACOG) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 9:50 PM EDT - 6 months ago

Alpha Cognition Inc. (ACOG) Q4 2024 Earnings Call Transcript

Alpha Cognition Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

Mar 31, 2025, 8:30 AM EDT - 6 months ago

Alpha Cognition Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

Mar 19, 2025, 4:30 PM EDT - 6 months ago

Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer's Disease

Mar 18, 2025, 8:30 AM EDT - 6 months ago

Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer's Disease

Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer's disease

Feb 12, 2025, 8:30 AM EST - 7 months ago

Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer's disease

Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG)

Jan 30, 2025, 11:05 AM EST - 8 months ago

Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG)

Alpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYL

Jan 14, 2025, 8:30 AM EST - 8 months ago

Alpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYL

Alpha Cognition Announces a $44 Million Exclusive Licensing Agreement for the Development and Commercialization of ZUNVEYL (benzgalantamine), an FDA-Approved Treatment for Mild-to-Moderate Alzheimer's Disease, in China

Jan 8, 2025, 8:30 AM EST - 9 months ago

Alpha Cognition Announces a $44 Million Exclusive Licensing Agreement for the Development and Commercialization of ZUNVEYL (benzgalantamine), an FDA-Approved Treatment for Mild-to-Moderate Alzheimer's Disease, in China

Alpha Cognition to Present Q1 2025 ZUNVEYL (benzgalantamine) Launch Strategy Targeting the $2 Billion U.S. Alzheimer's Long-Term Care Market During Investor Update Call

Jan 6, 2025, 8:30 AM EST - 9 months ago

Alpha Cognition to Present Q1 2025 ZUNVEYL (benzgalantamine) Launch Strategy Targeting the $2 Billion U.S. Alzheimer's Long-Term Care Market During Investor Update Call

Alpha Cognition Announces Partial Exercise of Over-allotment Option

Dec 16, 2024, 2:56 PM EST - 9 months ago

Alpha Cognition Announces Partial Exercise of Over-allotment Option

CSE Bulletin: Delist - Alpha Cognition Inc. (ACOG)

Dec 16, 2024, 11:51 AM EST - 9 months ago

CSE Bulletin: Delist - Alpha Cognition Inc. (ACOG)

Alpha Cognition Announces Voluntary Delisting from CSE

Dec 12, 2024, 6:41 PM EST - 9 months ago

Alpha Cognition Announces Voluntary Delisting from CSE

Alpha Cognition Announces Positive Interim Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury

Dec 11, 2024, 8:30 AM EST - 10 months ago

Alpha Cognition Announces Positive Interim Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury

Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update

Nov 15, 2024, 5:00 PM EST - 10 months ago

Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update

Alpha Cognition Announces Pricing of $50 Million Upsized Public Offering and Nasdaq Listing

Nov 12, 2024, 9:22 AM EST - 11 months ago

Alpha Cognition Announces Pricing of $50 Million Upsized Public Offering and Nasdaq Listing

MTBKNG9
MTBKNG9 Sep. 17 at 10:21 PM
$ACOG ...Had the same issue yesterday with Schwab, not good if you have to make a call to buy the stock, been lots of selling last two days so keep an eye out if it drops any lower it could set off a drastic move down....
0 · Reply
GeorgeJonesCountryMusic
GeorgeJonesCountryMusic Sep. 16 at 5:31 PM
$ACOG I’ve been buying shares all the time with Schwab and today got a message stating not eligible for electronic entry. Anybody else use Schwab ?
4 · Reply
AlanHR
AlanHR Sep. 12 at 7:21 PM
$ACOG The transcript of the CF fireside chat is now up on the AC website.
0 · Reply
kubota2323
kubota2323 Sep. 8 at 7:19 PM
$ACOG 50 ma is 9.35 now
0 · Reply
Logic102
Logic102 Sep. 8 at 2:06 PM
$ACOG Nice recent upward movement trend. Is some good sales data news leaking?
1 · Reply
FlowerInTheCellar
FlowerInTheCellar Sep. 8 at 11:40 AM
$ACOG https://www.marketbeat.com/instant-alerts/filing-alyeska-investment-group-lp-has-171-million-stock-holdings-in-alpha-cognition-inc-acog-2025-09-06/
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Sep. 5 at 2:24 PM
$ACOG Did anyone watch the conference? I was busy, unfortunately.
1 · Reply
jumptime
jumptime Sep. 4 at 5:44 PM
$ACOG Nice greenies.
0 · Reply
Logic102
Logic102 Sep. 4 at 1:46 PM
$ACOG I think this is pretty much dead money until more sales data comes out. I'm long term Bullish but have shifted most of my funds from here to LCTX and AVXL where I anticipate large upward moves soon. I respect those who are accumulating for the long haul.
0 · Reply
GeorgeJonesCountryMusic
GeorgeJonesCountryMusic Sep. 3 at 8:08 PM
$ACOG everyone still bullish here? I’ve been adding pretty regularly
1 · Reply
FlowerInTheCellar
FlowerInTheCellar Sep. 1 at 7:05 AM
$ACOG https://www.marketbeat.com/instant-alerts/alpha-cognition-nasdaqacog-upgraded-by-wall-street-zen-to-hold-rating-2025-08-30/
0 · Reply
Trex28
Trex28 Aug. 29 at 3:37 PM
$ACOG I like this price for more shares. I added some more shares for the long haul.
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Aug. 28 at 10:50 PM
$ACOG https://www.businesswire.com/news/home/20250828237481/en/Alpha-Cognition-Inc.-Nasdaq-ACOG-Announces-Participation-in-Key-September-Investor-Conferences
0 · Reply
Bioinvester001
Bioinvester001 Aug. 28 at 6:26 PM
$ACOG A nice corporate announcement since my last post. The days of a few traders controlling the daily sp with low volume is about ready to end in my opinion. The CEO has decided to let the world know about this company, and will be presenting at two conferences in the beginning of Sept. I will be looking for more volume over the next few months, and the sp will grind up if this is the case. Still adding!
0 · Reply
Logic102
Logic102 Aug. 27 at 2:59 PM
$ACOG Buy Low Sell High. The quarterly sales were somewhat disappointing after management was a bit overexuberant on the call the previous quarter regarding the initial product launch. I'm not throwing stones as I'd rather hear a very excited manager on a call than a cold fish. Initial sales for a small company product takes time to hit critical mass. It's a very good product for persons battling significant dementia. It will sell well.
0 · Reply
jumptime
jumptime Aug. 27 at 2:26 PM
$ACOG A little more active today so far...
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Aug. 26 at 8:51 AM
$ACOG https://www.youtube.com/watch?v=E-ZNyeds15g Many people probably watched the call live. Now it's online on YouTube.👍🏻
0 · Reply
Trex28
Trex28 Aug. 25 at 8:03 PM
$ACOG Picked up some more shares today at this low low rate.
0 · Reply
Bioinvester001
Bioinvester001 Aug. 25 at 2:20 PM
$ACOG The 75M shelf raise was smart as it is in place only if needed. I am continuing to add, and have done so the last six quarters. I think the next quarter will be exceptional, and looking for additional corporate announcements until then. Adding and holding!
1 · Reply
FlowerInTheCellar
FlowerInTheCellar Aug. 23 at 10:58 AM
$ACOG https://ng.investing.com/news/sec-filings/alpha-cognition-enters-75-million-atthemarket-offering-agreement-with-wainwright-93CH-2077450 "Alpha Cognition enters $75 million at-the-market offering agreement with Wainwright"
1 · Reply
jumptime
jumptime Aug. 22 at 9:00 PM
$ACOG Shelf.
0 · Reply
ForestFoxes
ForestFoxes Aug. 22 at 1:23 PM
15,000 shares of $ACOG at $8.4885 per share 👍 = $127,328 https://app.quotemedia.com/data/downloadFiling?webmasterId=99084&ref=319395917&type=HTML&symbol=ACOG&cdn=0381c7a86a11e96714f7a52c7926d8b3&companyName=Alpha+Cognition+Inc.&formType=4&formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&dateFiled=2025-08-21
0 · Reply